RedHill Biopharma reported $-4.22M in Operating Profit for its fiscal quarter ending in June of 2024.





Operating Profit Change Date
Cara Therapeutics USD -7.05M 1.11M Mar/2026
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
Cronos Group USD -1.45M 5.61M Mar/2026
RedHill Biopharma USD -4.22M 1.8M Jun/2024